Asking the question again: Are cation exchange resins effective for the treatment of hyperkalemia?

Nephrology Dialysis Transplantation

Volumn 27, Issue 12, 2012, Pages 4294-4297

  Kamel, Kamel S ^a,b   Schreiber, Martin ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

hyperkalemia; sodium polysterene sulfonate

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; PATIROMER; PLACEBO; POLYSTYRENESULFONATE SODIUM; POTASSIUM ION; RENIN INHIBITOR; SORBITOL; SPIRONOLACTONE;

ARTICLE; CATION EXCHANGE; CHRONIC DRUG ADMINISTRATION; CHRONIC KIDNEY FAILURE; CONSTIPATION; DISEASE CONTROL; DRUG BINDING; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HUMAN; HYPERKALEMIA; INTESTINE NECROSIS; INTESTINE PERFORATION; ISCHEMIC COLITIS; OLIGURIA; POTASSIUM EXCRETION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

CATION EXCHANGE RESINS; HUMANS; HYPERKALEMIA; POLYSTYRENES;

EID: 84871206319     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs293     Document Type: Article

References (23)

1. Sterns RH, Rojas M, Bernstein P et al. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol 2010; 21: 733-7355.
2. Watson M, Abbott KC, Yuan CM. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol 2010; 5: 1723-1726.
3. Kamel KS, Wei C. Controversial issues in treatment of hyperkalemia. Nephrol Dial Transpl 2003; 18: 2215-2218.
4. Emmett M, Hootkins RE, Fine KD. Effect of three laxatives and a cation exchange resin on fecal sodium and potassium excretion. Gastroenterology 1995; 108: 752-760.
5. Johnson LR. Fluid and electrolyte absorption. In: Johnson LR (ed). Gastrointestinal Physiology. 5th ed. Philadelphia, PA: Mosby-Yearbook Inc., 1997, pp. 135-145.
6. Binder HJ, Sandle GI. Electrolyte absorption and secretion in mammalian colon. In: Johnson LR (ed). Physiology of the Gastrointestinal Tract. New York, NY: Raven Press, 1987, pp. 1389-1418.
7. Kanaghinis T, Lubran M, Coghil NF. The composition of ileastomy fluid. Gut 1963; 4: 322-338.
8. Agarwal R, Afzalpurkar R, Fordtran J. Pathophysiology of potassium absorption and secretion by the human intestine. Gastroenterology 1994; 107: 548-571.
9. Sandle GI, Gaiger E, Tapster S et al. Evidence for large intestinal control of potassium homeostasis in uremic patients undergoing long term dialysis. Clin Science 1987; 73: 247-252.
10. Hayes CP, Jr, Robinson RR. Fecal potassium excretion in patients on chronic intermittent hemodialysis. Trans Am Soc for Artif Intern Organs 1965; 11: 242-2466.
11. Hayes CP, Jr, McLeod ME, Robinson RR. An extravenal mechanism for the maintenance of potassium balance in severe chronic renal failure. Trans Assoc Am Physicians 1967; 80: 207-216.
12. Flinn RB, Merrill JP, Welzant WR. Treatment of the oliguric patient with a new sodium-exchange resin and sorbitol. N Eng J Med 1961; 264: 111-115.
13. Scherr L, Ogden DA, Mead AW. Management of hyperkalemia with a cation-exchange resin. N Eng J Med 1961; 264: 115-119.
14. Bull GM, Carter AB, Lowe KG. Hyperpotassaemic paralysis. Lancet 1953; 265: 60-63.
15. Gerstman BB, Kirkman R, Platt R. Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate in sorbitol. Am J kidney Dis 1992; 20: 159-161.
16. McGowan CE, Saha S, Chu G et al. Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol. South Med J 2009; 102: 493-497.
17. Lillemoe KD, Romolo JL, Hamilton SR et al. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Surgery 1987; 101: 267-272.
18. Gruy-Kapral C, Emmett M, Santa Ana CA et al. Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease. J Am Soc Nephrol 1998; 9: 1924-1930.
19. Sandle GI, Hunter M. Apical potassium (BK) channels and enhanced potassium secretion in human colon. QJM 2010; 103: 85-89.
20. Pitt B, Anker SD, Bushinsky DA et al. Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a doubleblind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur heart J 2011; 32: 820-828.
21. Kamel KS, Halperin ML. Intrarenal urea recycling leads to a higher rate of renal excretion of potassium: an hypothesis with clinical implications. Curr Opin Nephrol Hypertens 2011; 20: 547-554.
22. Carlisle EJF, Donnelly SM, Ethier J et al. Modulation of the secretion of potassium by accompanying anions in humans. Kidney Intern 1991; 39: 1206-1212.
23. Steele A, deVeber H, Quaggin SE et al. What is responsible for the diurnal variation in potassium excretion? Am J Physiol 1994; 36: R554-R560.